Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Smoking Cessation on Sleep
NCT00132821Phase 4Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Aug 2005
- Primary completion
- May 2009
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupropion and nicotine patch in Tobacco Use Disorder (TUD) (4 arms), sponsored by National Institute on Drug Abuse. Primary endpoint: Pre- and post-cessation sleep measures by in-laboratory polysomnography. Started Aug 2005; status: completed.
02
Drugs
bupropionnicotine patch
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00132821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00132821.